# Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates

Study · id `cardio:ct-nct06256211` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06256211](<https://clinicaltrials.gov/study/NCT06256211>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06256211

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT06256211. Randomized; single masking; primary purpose treatment. Start 2024-03-01 (anticipated); primary completion 2024-11-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT06256211, source copy `cardio:ctgov-nct06256211-2024-02-13`, retrieved 2026-10-26)
- Planned start: 2024-03-01 (anticipated) (ClinicalTrials.gov record NCT06256211, source copy `cardio:ctgov-nct06256211-2024-02-13`, retrieved 2026-10-26)
- Primary completion: 2024-11-01 (anticipated) (ClinicalTrials.gov record NCT06256211, source copy `cardio:ctgov-nct06256211-2024-02-13`, retrieved 2026-10-26)
- Completion: 2024-12-30 (anticipated) (ClinicalTrials.gov record NCT06256211, source copy `cardio:ctgov-nct06256211-2024-02-13`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06256211-2024-02-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates
- Condition: Patent Ductus Arteriosus
- Intervention (Drug): Paracetamol
- Lead sponsor: Soha mahmoud Hussien mahdy
- Lead sponsor class: OTHER
- Collaborator: Assiut University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as a collaborator: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: 69f83d724859d567c1ef343864617d638d6000d045988b2f927ec7276cf85fad
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
